Trailblazers are pioneers; someone who forges forward where others do not, and sets the trail for others to follow.
It is estimated that there only 3000 antimicrobial resistance (AMR) researchers, yet we are faced with the challenge of an increasing burden of drug-resistant infections and diminishing treatment pipelines.
In 2024, the global community came together to drive collective action and sign a political declaration on AMR at the UN General Assembly meeting in New York. We now need to ensure we support those advocates and innovators who are helping to reduce the impact of AMR and halt the rising death rate and economic impact of drug-resistant infections.
Aims
The inaugural AMR Trailblazers programme has been established by CSIRO, Australia's national science agency, and the Fleming Initiative, an international programme led out of the UK's Imperial College London, to recognise the achievements of up to 20 women around the world who are leading and inspiring action on AMR.
The achievements of the Trailblazers will be celebrated and amplified through prominent profiles featured in a dedicated section of the Fleming Initiative website.
These profiles will showcase the Trailblazers' diverse expertise and contributions to minimising the impact of AMR and provide opportunities for them to connect with fellow experts, potential collaborators, and a global audience.
By supporting these women we look to achieve four key goals:
- Increase the number of women working in AMR-related fields and therefore contribute to efforts to redress inequity seen within Science, Technology, Engineering, Arts, and Medical (STEAM) careers.
- Highlight pioneering work being undertaken across sectors and in regions not captured by traditional academic literature.
- Build a stronger, more inclusive, and supportive AMR community.
- Continue to raise awareness amongst the public of antimicrobial resistance and improve collaborative efforts in the AMR space.
How to nominate
Nominations will be submitted through select organisations:
- CSIRO
- The Fleming Initiative
- Access to Medicine Foundation
- AMR Insights BV
- CARB-X
- LifeArc
- UN Foundation
- WHO Collaborating Centre for AMR, Doherty Institute, University of Melbourne
Individuals may be also directly invited to apply by the Fleming Initiative and CSIRO.
Download the brochure
Eligibility requirements
We welcome world-leading organisations to nominate women who are working to minimise AMR across disciplines and sectors that comprise a One Health approach (human, animal, and the environment).
These include, but are not limited to:
- R&D
- surveillance
- clinical and behavioural sciences
- education
- communications
- ethics
- policy
- law
- economics.
The work of the individual must be focussed on facets of AMR (including drug-resistant malaria and fungi) but not viral illnesses or general infectious diseases.
To achieve our goals, we are currently only taking nominations for those who identify as female.
Whilst we are not imposing geographic restrictions upon submissions, we encourage and will guide our expert panel to weight submissions to account for those who may be working in more resource-limited settings, or whose work looks to address inequity seen across and within populations with respect to AMR.
Provisional Timetable
- Nominations opening date: March 2025
- Nominations closing date: June 2025
- Assessment by the panel: September 2025
- Announcement: November 2025
Conditions
The Trailblazer finalists agree to be photographed, filmed and/or interviewed for non-commercial objectives and for Trailblazer-related purposes. These photos, videos and texts will be used in, but not limited to written press, television, internet, outdoor display, corporate publications, exhibitions.
Trailblazer images can be used for the promotion of science among the younger generation, particularly young women.
Each of the Trailblazers will sign a separate media release form. The Trailblazers will not receive any remuneration for such promotional activity.
Trailblazers are pioneers; someone who forges forward where others do not, and sets the trail for others to follow.
It is estimated that there only 3000 antimicrobial resistance (AMR) researchers, yet we are faced with the challenge of an increasing burden of drug-resistant infections and diminishing treatment pipelines.
In 2024, the global community came together to drive collective action and sign a political declaration on AMR at the UN General Assembly meeting in New York. We now need to ensure we support those advocates and innovators who are helping to reduce the impact of AMR and halt the rising death rate and economic impact of drug-resistant infections.
Aims
The inaugural AMR Trailblazers programme has been established by CSIRO, Australia's national science agency, and the Fleming Initiative, an international programme led out of the UK's Imperial College London, to recognise the achievements of up to 20 women around the world who are leading and inspiring action on AMR.
The achievements of the Trailblazers will be celebrated and amplified through prominent profiles featured in a dedicated section of the Fleming Initiative website.
These profiles will showcase the Trailblazers' diverse expertise and contributions to minimising the impact of AMR and provide opportunities for them to connect with fellow experts, potential collaborators, and a global audience.
By supporting these women we look to achieve four key goals:
- Increase the number of women working in AMR-related fields and therefore contribute to efforts to redress inequity seen within Science, Technology, Engineering, Arts, and Medical (STEAM) careers.
- Highlight pioneering work being undertaken across sectors and in regions not captured by traditional academic literature.
- Build a stronger, more inclusive, and supportive AMR community.
- Continue to raise awareness amongst the public of antimicrobial resistance and improve collaborative efforts in the AMR space.
How to nominate
Nominations will be submitted through select organisations:
- CSIRO
- The Fleming Initiative
- Access to Medicine Foundation
- AMR Insights BV
- CARB-X
- LifeArc
- UN Foundation
- WHO Collaborating Centre for AMR, Doherty Institute, University of Melbourne
Individuals may be also directly invited to apply by the Fleming Initiative and CSIRO.
Download the brochure
- Female trailblazers in AMR PDF (2 MB)
- Female trailblazers in AMR - accessible text version TXT (5 KB)
Eligibility requirements
We welcome world-leading organisations to nominate women who are working to minimise AMR across disciplines and sectors that comprise a One Health approach (human, animal, and the environment).
These include, but are not limited to:
- R&D
- surveillance
- clinical and behavioural sciences
- education
- communications
- ethics
- policy
- law
- economics.
The work of the individual must be focussed on facets of AMR (including drug-resistant malaria and fungi) but not viral illnesses or general infectious diseases.
To achieve our goals, we are currently only taking nominations for those who identify as female.
Whilst we are not imposing geographic restrictions upon submissions, we encourage and will guide our expert panel to weight submissions to account for those who may be working in more resource-limited settings, or whose work looks to address inequity seen across and within populations with respect to AMR.
Provisional Timetable
- Nominations opening date: March 2025
- Nominations closing date: June 2025
- Assessment by the panel: September 2025
- Announcement: November 2025
Conditions
The Trailblazer finalists agree to be photographed, filmed and/or interviewed for non-commercial objectives and for Trailblazer-related purposes. These photos, videos and texts will be used in, but not limited to written press, television, internet, outdoor display, corporate publications, exhibitions.
Trailblazer images can be used for the promotion of science among the younger generation, particularly young women.
Each of the Trailblazers will sign a separate media release form. The Trailblazers will not receive any remuneration for such promotional activity.